Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

CRTC vs CLOX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CLOX Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 3–0 Matrix Metrics)

CLOX Overall Winner 6-Pillar Tally: CRTC 0 – 0 CLOX (6 Tie) Matrix Metrics: CRTC 0 – 3 CLOX

As of Nov 20, 2026, Eldridge AAA CLO ETF (CLOX) is the stronger overall head-to-head candidate over Xtrackers US National Critical Technologies ETF (CRTC) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). CRTC carries a Unified Composite Score of 34.8/100 (SELL) at $36.17 (N/M Forward P/E, N/A operating margin), whereas CLOX carries 61.0/100 (BUY) at $25.58 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: CRTC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 25.0); meanwhile CLOX trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 53.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CRTC vs CLOX
CRTC NYSE Arca
Xtrackers US National Critical Technologies ETF
Institutional Equity
$36.17
-4.01% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.05β · 27% Vol
Unified Composite Score
34.8 / 100 SELL
Tech 15.0 Fund 49.0 Flow 50.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -1.2%), weak momentum, RSI 25
RSI-14: 25.0 · SMA20: $39.64 · SMA50: $40.70
CLOX NYSE Arca Head-to-Head Winner
Eldridge AAA CLO ETF
Institutional Equity
$25.58
-0.04% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -0.01β · 1% Vol
Unified Composite Score
61.0 / 100 BUY
Tech 68.0 Fund 60.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 53
RSI-14: 53.0 · SMA20: $25.57 · SMA50: $25.57

6-Pillar Scorecard Institutional Category Breakdown (CRTC 0 – 0 CLOX)

Columns: Metric · CRTC · CLOX
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CRTC (0) vs CLOX (3)
Institutional Metric CRTC CLOX Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
29% ($34–$42) 72% ($25–$26) Stronger Trend CLOX
Beta / 30D Volatility
Risk Regime
1.05β · 27% Vol -0.01β · 1% Vol Lower Realized Risk CLOX
Unified Institutional Score
Composite Signal
34.8 / 100 (SELL) 61.0 / 100 (BUY) Higher Composite CLOX
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CLOX +11.16 pp
CRTC: -11.08% · CLOX: +0.08%
3M Horizon CLOX +11.22 pp
CRTC: -11.0% · CLOX: +0.22%
6M Horizon CLOX +6.71 pp
CRTC: -6.83% · CLOX: -0.12%
1Y Horizon CRTC +0.86 pp
CRTC: +0.97% · CLOX: +0.11%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CRTC vs CLOX. Trailing 12-month operating profitability (CRTC N/A vs CLOX N/A) and valuation multiples (CRTC N/M vs CLOX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CRTC ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
CLOX ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CRTC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CRTC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CLOX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CLOX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CRTC Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CLOX Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CRTC vs CLOX Key Questions & Quantitative Answers

As of Nov 20, 2026, Eldridge AAA CLO ETF (CLOX) is the stronger overall head-to-head candidate over Xtrackers US National Critical Technologies ETF (CRTC) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). CRTC carries a Unified Composite Score of 34.8/100 (SELL) at $36.17 (N/M Forward P/E, N/A operating margin), whereas CLOX carries 61.0/100 (BUY) at $25.58 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: CRTC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 25.0); meanwhile CLOX trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 53.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CRTC and CLOX split Growth & Scale metrics: CRTC posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with CLOX at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, CRTC generates N/A in USD-normalized revenue versus N/A for CLOX. In operating R&D and SG&A reinvestment, CRTC deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CLOX.

CRTC and CLOX trade at balanced relative valuation multiples. CRTC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas CLOX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CRTC (N/A ROE) versus CLOX (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, CRTC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.05β · 27% Vol realized risk). By comparison, CLOX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.01β · 1% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.